Amendment106th Congress
974
- Amendment Number
- 974
- Purpose
- An amendment numbered 32 printed in the Congressional Record to require, upon FDA approval of a new drug, the disclosure of the taxpayer funded contribution to the total cost of research and development of said drug.
- Congress
- 106
- Type
- HAMDT
- Latest Action Date
- Jul 11, 2000
- Latest Action Text
- By unanimous consent, the Allen amendment was withdrawn.
- Latest Action Time
- 13:30:31
- Submitted Date
- Jul 11, 2000
- Chamber
- House of Representatives
- Update Date
- Aug 15, 2021